DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2209609/exploring-analyst-estimates-for-m-t-bank-corporation-mtb-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2209609 Jan 12, 2024 - Beyond analysts' top -and-bottom-line estimates for M&T Bank Corporation (MTB), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2212081/compared-to-estimates-m-t-bank-corporation-mtb-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2212081 Jan 18, 2024 - While the top- and bottom-line numbers for M&T Bank Corporation (MTB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0

https://www.zacks.com/stock/news/2215374/macy-s-m-stock-falls-amid-market-uptick-what-investors-need-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2215374 Jan 24, 2024 - In the closing of the recent trading day, Macy's (M) stood at $18.14, denoting a -0.27% change from the preceding trading day. 0

https://www.zacks.com/stock/news/2215875/m-a-com-mtsi-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2215875 Jan 25, 2024 - M/A-Com (MTSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2220331/bears-are-losing-control-over-b-m-european-value-retail-sa-unsponsored-adr-bmrry-here-s-why-it-s-a-buy-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2220331 Feb 02, 2024 - B&M European Value Retail SA Unsponsored ADR (BMRRY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. 0

https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-lly-s-q4-earnings-nvo-nvs-mrk-s-m-a-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2224190 Feb 09, 2024 - Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements. 0

https://www.zacks.com/stock/news/2228893/macy-s-m-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2228893 Feb 20, 2024 - In the most recent trading session, Macy's (M) closed at $19.26, indicating a -1.03% shift from the previous trading day. 0

https://www.zacks.com/stock/news/2232544/macy-s-lowe-s-beat-in-q4-durable-goods-lower?cid=CS-ZC-FT-ahead_of_wall_street-2232544 Feb 27, 2024 - We have some grist for the trading mill ahead of the opening bell, but it's not likely to cause any meaningful tremors from this vantage point. 0

https://www.zacks.com/stock/news/2245572/adtran-adtn-unveils-fsp-3000-m-flex800-for-network-operators?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2245572 Mar 25, 2024 - ADTRAN (ADTN) FSP3000 M-Flex800 leverages ZR and ZR+ pluggable optics and empowers operators to match high-capacity connectivity needs across a diverse range of applications. 0

https://www.zacks.com/stock/news/2247400/pharma-stock-roundup-abbv-nvo-s-new-m-as-fda-nod-to-jnj-mrk-pah-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-2247400 Mar 28, 2024 - While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs. 0